Latest Market Segmentation News

Liberty Metals Limited has strategically pivoted into the critical minerals sector with a $2.5 million capital raise, new board appointments, and acquisition of three major Brazilian projects targeting rutile, ilmenite, zircon, and rare earths.

GreenHy2 Limited has launched its PowerSafe Sodium-Ion Battery range tailored for Australian conditions, expanded into turnkey solar and battery solutions, and signed a strategic MOU with Skeleton Technologies to explore advanced energy storage in Australia.

Locate Technologies reported steady Q1 FY26 revenue with a strategic pivot to the NZX to better support its Bitcoin treasury ambitions. The company’s Locate2u unit showed promising growth, while Zoom2u faced challenges amid softer consumer spending.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.

Credit Corp Group has reaffirmed its FY26 guidance, highlighting robust earnings growth driven by operational improvements across its US debt buying and Australian/New Zealand lending segments.

Invion Limited has partnered with Protect Animal Health to explore Photosoft™, a novel photodynamic therapy, as a treatment for cancer in companion animals, targeting a booming pet cancer market.

Scout Security has raised a further $220,000 through a share placement, bringing total capital raised to $820,000, as it works toward resolving its trading suspension.

Perpetual Limited reported a robust first quarter for FY26, with growth across its Asset Management, Corporate Trust, and Wealth Management divisions, driven by strong market returns and strategic initiatives.

EROAD pivots strategically to prioritise ANZ electronic road user charging opportunities, revises FY26 guidance downward, and appoints John Scott as Executive Chair to steer growth.

Navigator Global Investments reports a 3% rise in total assets under management to USD 87 billion, driven by strong growth in Lighthouse Partners and private markets despite a challenging investment landscape.

Ionic Rare Earths Limited’s IXRO securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Hydralyte USA reports an 11% sales increase in Q3 2025, driven by strong summer demand and the launch of its innovative Hydralyte Plus Brain Support product featuring nootropics.